Manuscripts submitted to Pharmaceutical Papers undergo an initial evaluation by the editorial board to assess their relevance to the journal’s aims and scope, scientific quality, and compliance with the submission guidelines. Manuscripts that pass this screening are subjected to a double-blind peer review conducted by independent reviewers selected by the editor based on their expertise.

Review outcomes, including decisions of minor or major revision, are communicated to the authors for revision. Following resubmission, the editorial team makes the final decision regarding acceptance or rejection. Acceptance for publication is based on reviewers’ recommendations and the manuscript’s scientific merit.